ANGLE

Liquid Biopsy And Precision Medicine Will Reshape Cancer Care

AnalystHighTarget

Not Invested

Consensus Narrative from 3 Analysts

Published

15 Aug 25

Updated

15 Aug 25

AnalystHighTarget's Fair Value

UK£0.37

84.5% undervalued

15 Aug

UK£0.058

-57.4%

9.5%

Author's Valuation

UK£0.4

84.5% undervalued

AnalystHighTarget Fair Value

Narrative

Updates0

AnalystHighTarget Fair Value

UK£0.4

84.5% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

64.25%

Medical Equipment revenue growth rate

0.44%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

8.17%

Calculation

UK£682.32k

Earnings '28

218.61x

PE Ratio '28

UK£149.16m

Market Cap '28

UK£149.16m

Market Cap '28

318.55m

No. shares '28

UK£0.47

Share Price '28

UK£0.47 Share Price '28

Discounted to 2025 @ 8.23% p.a.

UK£0.37

Fair Value '25